Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.

C. R. BARD, INC. v. M3 SYS.

August 24, 1994

C. R. BARD, INC., Plaintiff-Counterdefendant,
v.
M3 SYSTEMS, INC., Defendant-Counterclaimant.


Conlon


The opinion of the court was delivered by: SUZANNE B. CONLON

C.R. Bard, Inc. ("Bard") sues M3 Systems, Inc. ("M3 Systems") for patent infringement. M3 Systems counterclaims for inequitable conduct and violations of the Sherman Act. After the parties filed a joint pretrial order, the court severed the trial into four distinct stages (i.e., a "quadrifurcated" trial). M3 Systems now seeks leave to file additional motions in limine.

 BACKGROUND

 DISCUSSION

 M3 Systems now seeks leave to file motions in limine nearly three months after the filing deadline. M3 Systems contends it was unaware of the issues it now raises until after the trial was quadrifurcated when the revised final pretrial order was submitted. In light of the confusion that may have arisen in the wake of the quadrifurcation order, leave is granted to file the first two in limine motions. However, the third motion is untimely. The court now addresses the merits of the motions. *fn1"

 1. Benson Smith's Testimony

 M3 Systems moves to exclude Benson Smith's testimony during the infringement phase of the trial. Smith is scheduled to testify regarding the commercial success of the patents at issue in this suit as well as the harm that Bard allegedly suffered as a result of M3 Systems' conduct. M3 Systems contends that Smith's testimony: (1) would lead to repetitive testimony (in violation of the quadrifurcation order); and (2) would introduce evidence into the infringement phase of trial that is solely relevant to invalidity and damages.

 In response, Bard does not claim that Smith's testimony regarding commercial success and alleged harm would be relevant to infringement. Instead, Bard argues that Smith's job duties *fn2" "place severe limitations on [his] availability to testify at trial." Response at 2. In addition, Bard contends that Smith's testimony regarding commercial success and harm will only last a half hour.

 Bard's purported reasons for introducing irrelevant testimony during the Infringement phase are unsound. The court quadrifurcated the trial to prevent the introduction of evidence that might confuse the jury or distract it from focusing on the relevant issues during any one phase of the trial. The parties may not ignore the court's ruling because of inconvenience. Nor may they argue that violations of the quadrifurcation order are de minimis. Bard may not introduce evidence during the infringement phase that it concedes is not relevant to the issue of infringement. M3 Systems' motion to bar evidence of commercial success and harm to Bard during the infringement phase is granted.

 2. Deposition Summaries

 M3 Systems moves to prevent Bard from introducing deposition summaries of M3 Systems' officers and other employees in lieu of live testimony. Deposition testimony of an opposing party or its designees may be "used by an adverse party for any purpose." Fed. R. Civ. P. 32(a)(2). Thus, Bard may introduce deposition testimony of M3 Systems' officers as substantive proof -- regardless of the availability of the officers. See Aetna Casualty & Surety Co. v. Guynes, 713 F.2d 1187, 1194 (5th Cir. 1983); Coughlin v. Capitol Cement Co., 571 F.2d 290, 308 (5th Cir. 1978). Accordingly, M3 Systems' motion in limine to exclude deposition summaries is denied. *fn3"

 3. Patent Damages


Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.